Established in 2019, Lanterne Dx’s 4500 sf laboratory is a state of the art facility equipped to meet your end-to-end research needs. LDX is a CAP-accredited and CLIA-certified full-service pre-clinical and clinical histopathology contract research organization (CRO) that offers services for translational and clinical research, including biomarker discovery, histopathology support, and digital pathology support. Comprised of PhD scientists, DVM and MD pathologists, image analysts, and certified histotechnicians the LDX team provides expertise and guidance in developing individualized biomarker strategies for clients. 

Lanterne Dx’s capabilities include qualitative and quantitative immunohistochemical, immunofluorescent, in situ hybridization, and microscopic applications. We deliver pre- and post-intervention analysis of clinically derived materials for diagnostics and characterization of anti-tumor efficacy endpoints. As a valuable compliment to the IHC services, LDX also offers the latest imaging technology with high-throughput brightfield and IF whole-slide scanners, image analysis software, and secure cloud-based image hosting.

From routine and specialized histology support to optimized or custom protocols for your IHC, IF, and ISH needs (monoplex or multiplex), Lanterne Dx can provide you with the most critical data for your biomarker strategies.